Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 35% ± 11% | |
retinal ganglion cell | 4 studies | 60% ± 28% | |
type II pneumocyte | 3 studies | 43% ± 15% | |
acinar cell | 3 studies | 49% ± 24% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 30% ± 9% | |
erythroblast | 3 studies | 32% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 3150.69 | 358 / 359 | 99% | 88.15 | 283 / 286 |
bladder | 100% | 1971.81 | 21 / 21 | 98% | 147.26 | 495 / 504 |
intestine | 97% | 743.52 | 937 / 966 | 99% | 83.10 | 521 / 527 |
ovary | 99% | 1501.74 | 179 / 180 | 96% | 39.50 | 414 / 430 |
liver | 100% | 2920.92 | 226 / 226 | 96% | 96.74 | 388 / 406 |
skin | 98% | 1074.87 | 1779 / 1809 | 95% | 53.65 | 450 / 472 |
pancreas | 100% | 7132.91 | 328 / 328 | 93% | 60.63 | 166 / 178 |
prostate | 95% | 520.80 | 232 / 245 | 98% | 41.88 | 490 / 502 |
uterus | 95% | 634.57 | 162 / 170 | 95% | 57.59 | 438 / 459 |
brain | 91% | 533.45 | 2406 / 2642 | 98% | 48.17 | 694 / 705 |
lung | 91% | 1261.05 | 524 / 578 | 97% | 56.01 | 1115 / 1155 |
breast | 88% | 430.46 | 405 / 459 | 96% | 52.13 | 1076 / 1118 |
esophagus | 90% | 599.35 | 1297 / 1445 | 93% | 61.84 | 171 / 183 |
adrenal gland | 100% | 2809.52 | 258 / 258 | 49% | 65.01 | 112 / 230 |
kidney | 78% | 360.76 | 69 / 89 | 51% | 11.30 | 459 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.96 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 317.58 | 1 / 1 |
muscle | 98% | 897.96 | 786 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 41.15 | 43 / 45 |
adipose | 89% | 414.09 | 1074 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 21.77 | 68 / 80 |
spleen | 76% | 266.22 | 182 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 69% | 258.28 | 924 / 1335 | 0% | 0 | 0 / 0 |
thymus | 43% | 138.12 | 280 / 653 | 24% | 5.83 | 146 / 605 |
heart | 40% | 135.97 | 341 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 24% | 758.32 | 224 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140077 | Biological process | positive regulation of lipoprotein transport |
GO_0032377 | Biological process | regulation of intracellular lipid transport |
GO_0001558 | Biological process | regulation of cell growth |
GO_0032383 | Biological process | regulation of intracellular cholesterol transport |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0005764 | Cellular component | lysosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0030867 | Cellular component | rough endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
GO_0015485 | Molecular function | cholesterol binding |
GO_0008142 | Molecular function | oxysterol binding |
Gene name | TMEM97 |
Protein name | TMEM97 protein (Transmembrane protein 97) Transmembrane protein 97 Sigma intracellular receptor 2 (S2R) (Sigma-2 receptor) (Sigma2 receptor) (Meningioma-associated protein 30) (MAC30) (Transmembrane protein 97) |
Synonyms | MAC30 S2R |
Description | FUNCTION: Sigma-2 receptor which contributes to ameliorate dysfunctional cellular processes and slow degenerative progression by regulating cell functions including cholesterol biosynthesis/trafficking, membrane trafficking, autophagy, lipid membrane-bound protein trafficking, and receptor stabilization at the cell surface (Probable). Forms a ternary complex with PGRMC1 receptor and low density lipoprotein receptor/LDLR at the plasma membrane, which increases LDLR-mediated LDL cholesterol internalization . Decreases lysosomal sterol transporter NPC1 availability to the cell, probably through NPC1-binding, hence controlling lipid transport, including cholesterol and LBPA, outside of late endosome/lysosome . Binds regio- and stereoselective ligand 20(S)-hydroxycholesterol (20(S)-OHC) which enhances TMEM97-NPC1 interaction and decreases TMEM97-PGRMC1 and TMEM97-TSPO interactions, thereby linking OHC binding to cholesterol homeostasis . Also able to bind cholesterol (By similarity). Binds histatin 1 (Hst 1)/HN1 salivary peptide at the ER membrane, which is critical for increasing mitochondria-ER contacts and stimulating Hst1 wound healing properties . May alter the activity of some cytochrome P450 proteins . Although shows homologies with sterol isomerases (EXPERA domain), not able to catalyze sterol isomerization (Probable) . However, may act as sensors of these molecules (Probable) . Acts as a quality control factor in the ER, promoting the proteolytic degradation of nonproductive and extramitochondrial precursor proteins in the ER membrane thus removing them from the ER surface (By similarity). . |
Accessions | ENST00000336687.6 ENST00000583381.5 ENST00000582113.1 ENST00000582384.1 ENST00000226230.8 J3KT68 Q86XC5 J3KTD1 Q5BJF2 |